Phase I/II Trial of Povidone-iodine (PVP-I) Nasal Swab For Preventing COVID-19 Spread in Healthy Subjects
Status:
Not yet recruiting
Trial end date:
2021-04-01
Target enrollment:
Participant gender:
Summary
Title: Phase I/II Trial (Safety and Dosing) of Povidone-iodine (PVP-I) Nasal Swab For
Preventing COVID-19 Spread in Healthy Subjects:
Summary: This study will evaluate in a PH I/II trial in healthy volunteers the safety and
tolerability of PVP-I nasal swabs daily application. The intent is to follow with a PH III
randomized controlled clinical trial to assess the capacity for PVP-I nasal swabs to mitigate
the transmission of respiratory viruses specifically COVID 19.